{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:41:39Z","timestamp":1747172499044,"version":"3.40.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ygyno.2017.10.031","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T09:17:05Z","timestamp":1510391825000},"page":"111-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-0352","authenticated-orcid":false,"given":"A.K.","family":"Lie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Trop\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.B.","family":"Skare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Jonassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Brusegard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"L\u00f6nnberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2017.10.031_bb0005","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.vaccine.2006.05.117","article-title":"Chapter 9: clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GCO.0b013e32835c5d10","article-title":"Primary human papillomavirus testing in organized cervical screening","volume":"25","author":"Dillner","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening. Second edition\u2013summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0020","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0025","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0035","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/ijc.30385","article-title":"Human papillomavirus testing versus cytology in primary cervical cancer screening: end-of-study and extended follow-up results from the Canadian cervical cancer screening trial","volume":"139","author":"Isidean","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0045","doi-asserted-by":"crossref","first-page":"946","DOI":"10.5858\/2003-127-946-FTDFTA","article-title":"Findings to date from the ASC-US-LSIL Triage Study (ALTS)","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia","volume":"96","author":"Arbyn","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2017.10.031_bb0055","doi-asserted-by":"crossref","first-page":"F107","DOI":"10.1016\/j.vaccine.2012.05.088","article-title":"New technologies and procedures for cervical cancer screening","volume":"30","author":"Cuzick","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cncy.21325","article-title":"Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types","volume":"121","author":"Verdoodt","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0070","first-page":"1","article-title":"Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme","author":"Haldorsen","year":"2014","journal-title":"Acta Oncol."},{"year":"2014","series-title":"Catch-HPV, What is Known About HPV-related Cancers in Norway, and How to Act? Cancer in Norway - Special Issue. Oslo","author":"Nyg\u00e5rd","key":"10.1016\/j.ygyno.2017.10.031_bb0075"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0080","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0085","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1128\/JCM.42.7.3176-3184.2004","article-title":"Detection and typing of human papillomavirus by e6 nested multiplex PCR","volume":"42","author":"Sotlar","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0090","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1128\/JCM.00265-12","article-title":"Cytology and human papillomavirus testing 6 to 12months after ASC-US or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds","volume":"50","author":"Trope","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ijc.25649","article-title":"Randomized health services study of human papillomavirus-based management of low-grade cytological abnormalities","volume":"129","author":"Dillner","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0100","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/bjc.2011.326","article-title":"HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study","volume":"105","author":"Kelly","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0105","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(03)00413-7","volume":"188","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0110","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","volume":"188","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2010.03.007","article-title":"HPV genotype distribution according to severity of cervical neoplasia","volume":"118","author":"Sjoeborg","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0120","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0125","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1002\/ijc.30032","article-title":"Evaluating HPV-negative CIN2+ in the ATHENA trial","volume":"138","author":"Petry","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1471-0528.13071","article-title":"HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis","volume":"122","author":"Rodriguez-Carunchio","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0135","first-page":"1394","article-title":"Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types","volume":"11","author":"Castle","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2017.10.031_bb0140","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S1386-6532(02)00187-7","article-title":"Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail","volume":"25","author":"Poljak","year":"2002","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0145","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ygyno.2005.02.026","article-title":"DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia","volume":"97","author":"Lie","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0150","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/JCM.01863-08","article-title":"Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia","volume":"47","author":"Trope","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2015.06.040","article-title":"A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results","volume":"138","author":"Schiffman","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0160","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ijc.30375","article-title":"A cohort study of cervical screening using partial HPV typing and cytology triage","volume":"139","author":"Schiffman","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0165","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/jnci\/92.6.464","article-title":"Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica","volume":"92","author":"Herrero","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127444","article-title":"Minor cytological abnormalities and up to 7-year risk for subsequent high-grade lesions by HPV type","volume":"10","author":"Persson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ygyno.2015.01.551","article-title":"Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial","volume":"137","author":"Monsonego","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2010.03.007","article-title":"HPV genotype distribution according to severity of cervical neoplasia","volume":"118","author":"Sjoeborg","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"S3","key":"10.1016\/j.ygyno.2017.10.031_bb0185","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2017.10.031_bb0190","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/AOG.0000000000001777","article-title":"Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia","volume":"128","author":"Bjorge","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.10.031_bb0195","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817314531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817314531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T02:29:19Z","timestamp":1659839359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817314531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0090825817314531"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.10.031","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}